0
Your cart

Your cart is empty

Books > Professional & Technical > Industrial chemistry & manufacturing technologies > Industrial chemistry > Pharmaceutical technology

Buy Now

The Organic Chemistry of Drug Design and Drug Action (Hardcover, 3rd edition) Loot Price: R2,215
Discovery Miles 22 150
You Save: R261 (11%)
The Organic Chemistry of Drug Design and Drug Action (Hardcover, 3rd edition): Richard B. Silverman, Mark W Holladay

The Organic Chemistry of Drug Design and Drug Action (Hardcover, 3rd edition)

Richard B. Silverman, Mark W Holladay

 (1 rating, sign in to rate)
List price R2,476 Loot Price R2,215 Discovery Miles 22 150 | Repayment Terms: R208 pm x 12* You Save R261 (11%)

Bookmark and Share

Expected to ship within 12 - 17 working days

Donate to Against Period Poverty

"The Organic Chemistry of Drug Design and Drug Action, Third Edition," represents a unique approach to medicinal chemistry based on physical organic chemical principles and reaction mechanisms that rationalize drug action, which allows the reader to extrapolate those core principles and mechanisms to many related classes of drug molecules. This new edition reflects significant changes in the process of drug design over the last decade. It preserves the successful approach of the previous editions while including significant changes in format and coverage.

New to this edition: Updates to all chapters, including new examples and referencesChapter 1 (Introduction): Completely rewritten and expanded as an overview of topics discussed in detail throughout the bookChapter 2 (Lead Discovery and Lead Modification): Sections on sources of compounds for screening including library collections, virtual screening, and computational methods, as well as hit-to-lead and scaffold hopping; expanded sections on sources of lead compounds, fragment-based lead discovery, and molecular graphics; and deemphasized solid-phase synthesis and combinatorial chemistryChapter 3 (Receptors): Drug-receptor interactions, cation-p and halogen bonding; atropisomers; case history of the insomnia drug suvorexantChapter 4 (Enzymes): Expanded sections on enzyme catalysis in drug discovery and enzyme synthesisChapter 5 (Enzyme Inhibition and Inactivation): New case histories: for competitive inhibition, the epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib and Abelson kinase inhibitor, imatinibfor transition state analogue inhibition, the purine nucleoside phosphorylase inhibitors, forodesine and DADMe-ImmH, as well as the mechanism of the multisubstrate analog inhibitor isoniazidfor slow, tight-binding inhibition, the dipeptidyl peptidase-4 inhibitor, saxagliptinChapter 7 (Drug Resistance and Drug Synergism): This new chapter includes topics taken from two chapters in the previous edition, with many new examplesChapter 8 (Drug Metabolism): Discussions of toxicophores and reactive metabolitesChapter 9 (Prodrugs and Drug Delivery Systems): Discussion of antibody-drug conjugates

General

Imprint: Academic Press Inc
Country of origin: United States
Release date: May 2014
First published: 2015
Authors: Richard B. Silverman • Mark W Holladay
Dimensions: 288 x 223 x 27mm (L x W x T)
Format: Hardcover
Pages: 517
Edition: 3rd edition
ISBN-13: 978-0-12-382030-3
Categories: Books > Science & Mathematics > Chemistry > Organic chemistry > General
Books > Professional & Technical > Industrial chemistry & manufacturing technologies > Industrial chemistry > Pharmaceutical technology
LSN: 0-12-382030-8
Barcode: 9780123820303

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners